Literature DB >> 20705605

Effect of trehalose on the properties of mutant {gamma}PKC, which causes spinocerebellar ataxia type 14, in neuronal cell lines and cultured Purkinje cells.

Takahiro Seki1, Nana Abe-Seki, Takahiro Kikawada, Hideyuki Takahashi, Kazuhiro Yamamoto, Naoko Adachi, Shigeru Tanaka, Izumi Hide, Naoaki Saito, Norio Sakai.   

Abstract

Several missense mutations in the protein kinase Cγ (γPKC) gene have been found to cause spinocerebellar ataxia type 14 (SCA14), an autosomal dominant neurodegenerative disease. We previously demonstrated that the mutant γPKC found in SCA14 is susceptible to aggregation, which induces apoptotic cell death. The disaccharide trehalose has been reported to inhibit aggregate formation and to alleviate symptoms in cellular and animal models of Huntington disease, Alzheimer disease, and prion disease. Here, we show that trehalose can be incorporated into SH-SY5Y cells and reduces the aggregation of mutant γPKC-GFP, thereby inhibiting apoptotic cell death in SH-SY5Y cells and primary cultured Purkinje cells (PCs). Trehalose acts by directly stabilizing the conformation of mutant γPKC without affecting protein turnover. Trehalose was also found to alleviate the improper development of dendrites in PCs expressing mutant γPKC-GFP without aggregates but not in PCs with aggregates. In PCs without aggregates, trehalose improves the mobility and translocation of mutant γPKC-GFP, probably by inhibiting oligomerization and thereby alleviating the improper development of dendrites. These results suggest that trehalose counteracts various cellular dysfunctions that are triggered by mutant γPKC in both neuronal cell lines and primary cultured PCs by inhibiting oligomerization and aggregation of mutant γPKC.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20705605      PMCID: PMC2963337          DOI: 10.1074/jbc.M110.146704

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  48 in total

1.  Protein kinase C gamma, a protein causative for dominant ataxia, negatively regulates nuclear import of recessive-ataxia-related aprataxin.

Authors:  Hirohide Asai; Makito Hirano; Keiji Shimada; Takao Kiriyama; Yoshiko Furiya; Masanori Ikeda; Takaaki Iwamoto; Toshio Mori; Kazuto Nishinaka; Noboru Konishi; Fukashi Udaka; Satoshi Ueno
Journal:  Hum Mol Genet       Date:  2009-06-26       Impact factor: 6.150

2.  Mutant protein kinase C gamma that causes spinocerebellar ataxia type 14 (SCA14) is selectively degraded by autophagy.

Authors:  Kazuhiro Yamamoto; Takahiro Seki; Naoko Adachi; Tetsuya Takahashi; Shigeru Tanaka; Izumi Hide; Naoaki Saito; Norio Sakai
Journal:  Genes Cells       Date:  2010-04-11       Impact factor: 1.891

3.  Mutant gammaPKC found in spinocerebellar ataxia type 14 induces aggregate-independent maldevelopment of dendrites in primary cultured Purkinje cells.

Authors:  Takahiro Seki; Takayuki Shimahara; Kazuhiro Yamamoto; Nana Abe; Taku Amano; Naoko Adachi; Hideyuki Takahashi; Kaori Kashiwagi; Naoaki Saito; Norio Sakai
Journal:  Neurobiol Dis       Date:  2008-11-08       Impact factor: 5.996

4.  PKC gamma mutations in spinocerebellar ataxia type 14 affect C1 domain accessibility and kinase activity leading to aberrant MAPK signaling.

Authors:  Dineke S Verbeek; Joachim Goedhart; Laurie Bruinsma; Richard J Sinke; Eric A Reits
Journal:  J Cell Sci       Date:  2008-06-24       Impact factor: 5.285

5.  Aggregate formation of mutant protein kinase C gamma found in spinocerebellar ataxia type 14 impairs ubiquitin-proteasome system and induces endoplasmic reticulum stress.

Authors:  Takahiro Seki; Hideyuki Takahashi; Naoko Adachi; Nana Abe; Takayuki Shimahara; Naoaki Saito; Norio Sakai
Journal:  Eur J Neurosci       Date:  2007-11-14       Impact factor: 3.386

6.  Mutations in TTBK2, encoding a kinase implicated in tau phosphorylation, segregate with spinocerebellar ataxia type 11.

Authors:  Henry Houlden; Janel Johnson; Christopher Gardner-Thorpe; Tammaryn Lashley; Dena Hernandez; Paul Worth; Andrew B Singleton; David A Hilton; Janice Holton; Tamas Revesz; Mary B Davis; Paola Giunti; Paolo Giunti; Nicholas W Wood
Journal:  Nat Genet       Date:  2007-11-25       Impact factor: 38.330

7.  Enzymological analysis of mutant protein kinase Cgamma causing spinocerebellar ataxia type 14 and dysfunction in Ca2+ homeostasis.

Authors:  Naoko Adachi; Takeshi Kobayashi; Hideyuki Takahashi; Takumi Kawasaki; Yasuhito Shirai; Takehiko Ueyama; Toshio Matsuda; Takahiro Seki; Norio Sakai; Naoaki Saito
Journal:  J Biol Chem       Date:  2008-05-22       Impact factor: 5.157

8.  Trehalose impairs aggregation of PrPSc molecules and protects prion-infected cells against oxidative damage.

Authors:  Florence Béranger; Carole Crozet; Andrew Goldsborough; Sylvain Lehmann
Journal:  Biochem Biophys Res Commun       Date:  2008-07-03       Impact factor: 3.575

Review 9.  Trehalose: a review of properties, history of use and human tolerance, and results of multiple safety studies.

Authors:  A B Richards; S Krakowka; L B Dexter; H Schmid; A P M Wolterbeek; D H Waalkens-Berendsen; A Shigoyuki; M Kurimoto
Journal:  Food Chem Toxicol       Date:  2002-07       Impact factor: 6.023

10.  Mechanism allowing an insect to survive complete dehydration and extreme temperatures.

Authors:  M Watanabe; T Kikawada; N Minagawa; F Yukuhiro; T Okuda
Journal:  J Exp Biol       Date:  2002-09       Impact factor: 3.312

View more
  9 in total

1.  Testosterone promotes GPX5 expression of goat epididymal epithelial cells cultured in vitro.

Authors:  Zhaojin Luan; Xiaomei Fan; Huizi Song; Ruilan Li; Wenguang Zhang; Jiaxin Zhang
Journal:  In Vitro Cell Dev Biol Anim       Date:  2019-08-19       Impact factor: 2.416

2.  Pharmacological induction of heat shock proteins ameliorates toxicity of mutant PKCγ in spinocerebellar ataxia type 14.

Authors:  Aoi Nakazono; Naoko Adachi; Hideyuki Takahashi; Takahiro Seki; Daizo Hamada; Takehiko Ueyama; Norio Sakai; Naoaki Saito
Journal:  J Biol Chem       Date:  2018-08-09       Impact factor: 5.157

3.  Hypertonic stress induces rapid and widespread protein damage in C. elegans.

Authors:  Kris Burkewitz; Keith Choe; Kevin Strange
Journal:  Am J Physiol Cell Physiol       Date:  2011-05-25       Impact factor: 4.249

4.  Trehalose attenuates the gait ataxia and gliosis of spinocerebellar ataxia type 17 mice.

Authors:  Zhi-Zhong Chen; Chien-Ming Wang; Guan-Chiun Lee; Ho-Chiang Hsu; Tzu-Ling Wu; Chia-Wei Lin; Chih-Kang Ma; Guey-Jen Lee-Chen; Hei-Jen Huang; Hsiu Mei Hsieh-Li
Journal:  Neurochem Res       Date:  2015-02-12       Impact factor: 3.996

Review 5.  Potential applications of stress solutes from extremophiles in protein folding diseases and healthcare.

Authors:  Carla D Jorge; Nuno Borges; Irina Bagyan; Andreas Bilstein; Helena Santos
Journal:  Extremophiles       Date:  2016-04-12       Impact factor: 2.395

6.  Trehalose maintains vitality of mouse epididymal epithelial cells and mediates gene transfer.

Authors:  Bin Qu; Yihua Gu; Jian Shen; Jinzhou Qin; Jianqiang Bao; Yuan Hu; Wenxian Zeng; Wuzi Dong
Journal:  PLoS One       Date:  2014-03-20       Impact factor: 3.240

7.  Paraneoplastic CDR2 and CDR2L antibodies affect Purkinje cell calcium homeostasis.

Authors:  Manja Schubert; Debabrata Panja; Mette Haugen; Clive R Bramham; Christian A Vedeler
Journal:  Acta Neuropathol       Date:  2014-10-24       Impact factor: 17.088

8.  Trehalose reduces retinal degeneration, neuroinflammation and storage burden caused by a lysosomal hydrolase deficiency.

Authors:  Parisa Lotfi; Dennis Y Tse; Alberto Di Ronza; Michelle L Seymour; Giuseppe Martano; Jonathan D Cooper; Fred A Pereira; Maria Passafaro; Samuel M Wu; Marco Sardiello
Journal:  Autophagy       Date:  2018-07-23       Impact factor: 16.016

9.  Trehalose alleviates the phenotype of Machado-Joseph disease mouse models.

Authors:  Magda M Santana; Susana Paixão; Janete Cunha-Santos; Teresa Pereira Silva; Allyson Trevino-Garcia; Laetitia S Gaspar; Clévio Nóbrega; Rui Jorge Nobre; Cláudia Cavadas; Hagar Greif; Luís Pereira de Almeida
Journal:  J Transl Med       Date:  2020-04-09       Impact factor: 5.531

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.